🔥Telegram İfşa

On World Ovarian Cancer day, GenoME Diagnostics are delighted to launch our website and social media platforms. Follow us here genomediagnostics.co.uk for more info on our development of a novel blood test for earlier and more accurate diagnosis of OC! #WOCD21 @OvarianCancerDY

As a new Queen's University Belfast 🎓 @QubPGJCCR spinout, our work stems from a decade of research. We are developing a novel blood test to improve on CA125 for earlier and more accurate diagnosis of #OvarianCancer to improve patient outcome! #WOCD21

By 2040 we will see an ↑ in #ovariancancer by 42% and mortality by 50%. Tools for screening and early diagnosis are needed now so #NoWomanLeftBehind. Follow us here genomediagnostics.co.uk for more info on our novel #liquidbiopsy for earlier and more accurate diagnosis of OC

Awareness and Action are #PowerfulTogether so #NoWomanLeftBehind #EarlyDiagnosisSavesLives Breakthrough Cancer Research @isgoppi @ovacare @ovariancancerco National Ovarian Cancer Coalition @targetovarian Ovarian Cancer Action The Eve Appeal GRACE Charity IGCS Women's Health Innovation Coalition The Patrick G Johnston Centre for Cancer Research #WOCD21 #TEAlights

On #InternationalWomensDay we wish to congratulate our Chief Operations Officer Shannon Beattie on receiving a Women in Innovation award Innovate UK #OvarianCancer #earlydetection theguardian.com/society/2022/m…

On International Women's Day, we are delighted to announce that we have closed our Pre-Series A funding to enhance development of our #ovariancancer test (and beyond). Qubis ClarendonFM Deepbridge Capital @QubPGJCCR #IWD23